Actors of pharmaceuticals and beauty industries have gone to European courts to challenge an order that forcing at least 80% of the treatment in treatment aimed at removing microcontains from urban sewage.
Las Pharmaceuticals And cosmetics have filed an appeal before the European Union’s court Cure. European order that came into effect on January 1, 2025, forcing Drug and cosmetics manufacturers To eliminate microcontaminnts from urban wastewater, to finance at least 80% of the treatment, as per the principle “Who pollutes the wage.”
More than 90% of “Microchondaminnt Sewage treatment plants“” They are from medicine and cosmetic products, “said European President Europe’s Hans Gusans. According to his opinion, So 80% of the “elimination cost is” reasonable “ They are in charge of those who make them from these waste. “The pollution of those who pollute the base is the source of the European Environmental Policy,” he added.
Loading
For its part, the The fields of medicine and cosmetics They consider the load to be evenly distributed evenly. “We are all in favor of paying us a similar part of us The pollution we are creatingBut it must be a reasonable part, ”he told Nathali Mol, the general director of European pharmaceutical industries and associations.
“We try to find out who different pollutants are All actors participate in ensuring that this important order is established in the right principles. Not only does it similar to them, but also to be encouraged to produce more stable products in the future, ”he added. Efpia’s director also regrets The European Commission’s instruction and data did not access.
A bulky invoice
Commission estimates 1.2 billion euros per year Additional treatment at wastewater treatment stations. Some say that this is a fall in the sea compared to business size PharmaceuticalDrugs for Europe assume that this order is “unpredictable” and is at risk of access Fan of the drug.
“Since we cannot legally increase Drug price In Europe, it (order) this drug does not make patients available, creating Scarcity tsunami“Medical General Director of Europe said Adrian Von Den Howan.
For example, says The cost of diabetic medicine Metformin can increase to 900% and amoxicillin antibiotic to 350%. Overall, Agents of Drugs and Makeup Industries, including Healthcare France, Dermaparum, Epia, Reached Pharma, Hexel and cosmetic Europe, Have filed 16 resources Before the court of the EU. Poland has taken the matter before the EU court.
The Commission Reply
Communication with ‘Euronevs’ ensures the potential consequences of the manufacturer’s expanded responsibility Pharmaceutical They are carefully evaluated in the impact assessment. “Prices of Pharmaceutical Products” and “reduction Profit limits The industry should be somewhat, ”says a commission spokesman.
He’s it “the The order gives to states Significant flexibility and not affected by members to calculate the rates and ensure what they are provided Price of access and drugs. “
